Nam · PloS one 2024 · cross-sectional survey study · n=?

Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project.

Cited 38 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Animal/veterinary research without human clinical data (Level 4 cross-sectional by design analogy)

PubMed 38232117 · doi:10.1371/journal.pone.0295840 · record verified 2026-08-26

What was done

Researchers analyzed owner-reported survey data on disease history and body weight from companion dogs enrolled in the Dog Aging Project. They evaluated how body size (weight) associates with lifetime prevalence across various disease categories across age, examining size-by-age interactions while controlling for sex, purebred versus mixed-breed status, and geographic region.

What was found

The abstract reports directional associations without numerical data (effect sizes, p-values, or sample counts are not provided). Dog size showed a significant positive association with the lifetime prevalence of skin, bone/orthopedic, gastrointestinal, ear/nose/throat, cancer/tumor, brain/neurologic, endocrine, and infectious diseases. Dog size was negatively associated with ocular, cardiac, liver/pancreas, and respiratory diseases. Kidney/urinary disease prevalence did not vary significantly by size. The relationship between age and lifetime prevalence varied by dog size for ocular, cardiac, orthopedic, ear/nose/throat, and cancer conditions. Controlling for covariates did not meaningfully alter these patterns.

Why it matters

This study maps how canine body size shapes specific disease susceptibilities across the lifespan, providing context for why larger dogs experience reduced longevity.

Limits

The abstract provides no sample size, effect sizes, confidence intervals, or test statistics. Data rely on subjective owner reports rather than validated veterinary medical records, introducing potential misclassification and recall bias. As a cross-sectional observational analysis, survivorship bias may influence lifetime prevalence across older age cohorts.

Cited by